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Abstract 
 
 
 In 2007, pediatric gastroenterologists from ten practice sites across the U.S. created a 
quality improvement collaborative, now known as ImproveCareNow, to improve the quality of 
care provided to children with inflammatory bowel disease. Despite the face validity and great 
potential of quality improvement collaboratives, investigators do not fully understand how 
improvement happens, including the variables contributing to quality measures and the 
necessary components needed to sustain quality improvement. The purpose of this project was 
to explore perceptions of collaborative participants to identify elements of sustainability.  
We performed qualitative interviews with 16 ImproveCareNow participants as one method in a 
triangulated strategy of measuring collaborative participants’ perceptions. We selected 
informants from a diverse list of practice types and geographic locations, and asked open-ended 
questions, which we then transcribed and coded.  For this master’s paper, I analyzed members’ 
perceptions of value of, and implementation strategies for, collaborative components like pre-
visit planning, patient databases (population management), standardized clinic forms and 
algorithms, and decision support.   
I found that collaborative participants value many system-wide features of collaborative 
participation, but sites have different paths to implementation, and important features are under-
developed or under-utilized at some sites.   Respondents embraced the potential of population 
management reports, but noted that data entry burdened clinic flow.  Previsit planning was cited 
as moderately successful, and one site had developed a novel modification of the planning to 
obviate face-to-face meetings.  Standardized clinic templates and decision analysis tools met 
high expectations for mutual benefit from individual innovation and ingenuity.    
Analyzing in-depth interviews of ICN participants is the first step in understanding what 
health care providers perceive as the value from, benefits of, and challenges to initiating and 
sustaining collaborative quality improvement activities  
    
Perspective (Author’s Note) 
 
This master’s paper represents a component of a larger team project that allowed my 
friend and colleague Erica Peterson and I to utilize qualitative research tools to examine a 
pediatric IBD quality improvement collaborative. Working together, we were able to assess the 
perspectives of collaborative participants and explore the literature surrounding quality 
improvement collaboratives in greater depth than possible had there been just one of us. 
Therefore, the work completed for the master’s paper and practicum requirements was a 
collaborative effort itself, in which we both contributed equally at every stage.  
Although our master’s project examined the perceptions of participation in a pediatric 
IBD collaborative, I focused on the practice variation and implementation of key ICN activities, 
while Erica chose to focus on elements of sustainability of particular ICN activities and the 
Improve Care Now (ICN) collaborative itself.  We hope to present our combined work to the ICN 
Research Committee in the fall, at which time we will present data from a web-based survey 
that we constructed.  A complete discussion of the derivation and analysis of the survey results, 
as well as conclusions drawn from collected data, are largely beyond the scope of this project.  
Still, the in-depth interviews we conducted with health care providers were very engrossing, and 
allowed us to observe and analyze perspectives of individuals with varying interests and roles in 
quality improvement.  Overall, sustaining quality improvement requires systems change and 
commitment at all levels of the health care system. 
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Introduction 
Inflammatory bowel diseases in pediatric gastroenterology affect many children in the 
United States.1  Estimates of those affected range from 30 to 50 per 100,000 children and from 
24 to 30 per 100,000 children in the U.S. for Crohn’s and Ulcerative colitis, respectively.1    
Despite published standards of care and high levels of physician training, significant provider- 
and center-dependent variation exists in many spectra of medical care, and pediatric IBD is no 
exception.2, 3  Evidence specific to pediatric IBD helped to broaden and further highlight the 
importance of quality improvement for chronic illness care, an undertaking begun in earnest 
following publication of the seminal reports published by the Institute of Medicine, entitled To Err 
is Human4  and Crossing the Quality Chasm.5     
 In the mid-1990s, the Institute for Healthcare Improvement developed the Breakthrough 
Series collaborative model, legitimizing a model for quality improvement and spawning new 
attempts to reorganize and improve care.6, 7   Quality improvement collaboratives bring together 
multidisciplinary teams under the leadership of quality improvement experts.  They are designed 
to complement medical care with common goal-setting, behavioral and psychosocial 
interventions, and self-management principles to help change the way medical care is 
delivered.3, 8, 9 . The quality improvement literature suggests that minimizing variations in 
practice and carefully collecting data on processes of care and outcomes requires multi-level 
changes to health systems.10-12   Implementation of successful interventions like these requires 
a shift in focus, from short-term acute care to patient-centered chronic care, involving six core 
areas for improvement as part of the Chronic Care Model: linkages to community resources, 
self-management support, decision support, delivery system design, clinical information 
systems, and organization of the health interventions.   13, 14   
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 Early in 2007, leaders in pediatric IBD and quality improvement experts came together to 
form the PIDBNet Quality Improvement Collaborative.15  for pediatric inflammatory bowel 
disease.  Originally involving 10 sites as an extension of PIBDNet’s studies on variations in 
pediatric Crohn’s disease, the collaborative, now designated as ImproveCareNow (ICN), 
currently involves 24 centers.   Data collected by the collaborative show a drastically improved 
rate of Crohn’s remission among enrolled patients.  Since early 2008, the proportion of Crohn’s 
disease patients with disease in remission has progressively increased, from 49% to 64%.   
 The aim of our project was to explore and assess the perceptions of key participants in 
this collaborative, through in-depth interviews with key participants in its function, including 
physicians, nurses, and quality improvement professionals. We sought to place the activities 
and outcomes targets in an organizational context, exploring the expectations, perceived utility, 
and obstacles to implementations of key collaborative interventions, while describing the 
mechanisms of quality improvement at participating sites. 
 
Methods 
 We used the following three methods of analysis to identify and verify perceptions of 
participation in ICN: (1) in-depth structured interviews, (2) a web-based survey of collaborative 
participants, and (3) observation of participants at an ICN learning session. This mixed-method 
analysis allowed us to triangulate our approach to accurately reflect the perceptions and 
characteristics of ICN collaborative participants. The University of North Carolina IRB reviewed 
our research protocols and determined that we were exempt from obtaining informed consent. 
 The sampling strategy used to identify potential respondents combined purposive and 
chain-referral methods, often used if randomized selection is not appropriate.16   We selected 
respondents based on the heterogeneity of their practice, and used the collaborative database 
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to identify primary investigators from 10 of ICN’s sites.  Some demographic data are presented 
in Figure 1.  Second respondents from selected sites were identified through a reputational 
process, so that the most involved non-MD participants would be identified.  Of the 16 
interviews conducted (involving 10 sites), 14 were able to be recorded.  One provider did not 
grant permission for voice recording, and with one interview technical difficulties precluded 
recording.   Completed transcripts were sent to each key respondent.   
 With our interview being founded upon open-ended questions, construction of our code 
list was done through an inductive process, based on the responses we received. Interview 
coding was performed according to a multi-step analytic method similar to that described by 
Burnard.17   In all, 42,780 words were transcribed, equaling 91 typed pages of interview data.  
Upon completing all of the interviews and transcriptions, complete copies were distributed to 
both reviewers.  Each reviewer read the transcriptions carefully and took additional notes, 
seeking to enter the respondent’s “frame of reference.”18    
The codebook used to categorize our findings was constructed using a combination of 
open and selective coding strategies, the former advantageous for coding open-ended interview 
questions.19   Respondent answers were categorized according to theme, based on the question 
that was asked.   We began with 19 code headings and, constructing a code heading list in an 
iterative manner, created a final list of 39 code headings.  This was done in a cooperative 
manner by both researchers (see Table 1). Multiple coding can help minimize potential 
subjective biases when assigning categories to respondent data, and although intensive in 
nature, can lead to further refinement of coding headings 20  allowing for a more elaborate and 
thorough thematic analysis. 21   Analysis of codebook data was based on descriptive statistics, 
with content analysis based on recurring themes among respondent answers. 
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 We created a short, nine-question survey founded entirely on information from the 
qualitative interviews.  We sought to describe the perceptions of all participants in the 
collaborative, so we did not construct a sample of these participants, but invited every active 
participant to participate.  Primary investigators at each of 24 sites were contacted and asked to 
provide a complete list of individuals at their site who are involved in clinical care of patients at 
that institution, with the understanding that these numbers would vary across sites.   We 
obtained the ICN email contact list from the project manager and supplemented the included 
email addresses with those obtained from the email query, leading to a total sample of 90 
individuals who were invited to participate.  New sites were asked only to complete an 
abbreviated survey, assessing the relative importance of motivational factors for participating in 
the collaborative.    The survey results will be reported and analyzed in a subsequent 
manuscript.    
 
RESULTS 
 In general, sites instituted a wide range of activities (see Table 2, Figure 2). Interviewees 
in general felts that instruction in quality improvement, founded on the principles of Langley and 
colleagues, was very effective, as were interactions with peers attempting their own Plan-Do-
Study-Act cycles.  Small tests of change likely encourage active learning of QI methods by trial 
and error, and clinicians are able to better mold quality improvement into the fabric of their 
particular clinic, and in previous work researchers have shown that testing changes this way 
leads to faster improvements.22   Interviewees seemed to equate a fondness for intra- and inter-
team interactions (9 out of 16 interviewees posited interactions and teamwork as primary 
motivators to join a collaborative) with a different attitude about what quality improvement 
means.  One respondent commented that quality improvement through the collaborative differed 
strikingly from the version of “quality” that many health providers know, one based on increased 
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requirements for care, often construed by individuals who do not share the personal and 
professional concerns of physicians. 
 
Previsit Planning 
 As part of their quality improvement activities, sites participating in ImproveCareNow are 
asked to conduct previsit assessments of their patients with IBD.   Similar previsit work has also 
been a part of other chronic disease collaboratives.23, 24   For many sites in our sample, previsit 
planning occurs in once-weekly or twice-monthly sessions, with meetings composed of health 
professionals with many different roles.  Although this approach is fairly time consuming, 
discussing the management plan for a patient allows the physician to walk into the exam room 
with a deeper understanding of the patient’s history, and with a tentative management plan that 
is much more specific and tailored to each particular patient.  According to one respondent, 
save for standardized clinic intake and recording measures, previsit planning was one of the first 
things implemented by the collaborative.  Intended largely to encourage greater attention to 
medication dosing and nutrition and growth information, these visits can also be used to obtain 
needed tests or consultations more quickly than before.  Many respondents (83%) mentioned 
the previsit planning sessions as being an important component of quality improvement work at 
their site, and their perceptions of purpose and utility of these sessions was largely positive.  
One respondent described previsit planning sessions as being very successful, especially in 
comparison to the other patients seen in their gastroenterology practice: 
This is the first subset of our total patient population that we’re actually spending some 
time thinking about in advance of their appointments, which I think I is big improvement for 
us. 
As one respondent described, this can shift the focus of the patient’s visit, allowing a physician 
to focus “more on the problems they have, rather than the general information-gathering that 
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you typically have with a clinic visit.” One site has monthly sessions, corresponding to a monthly 
clinic day dedicated solely to IBD patients.  For one site, obstacles have prevented regular 
previsit meetings from occurring.  A respondent from this site attributed this to personnel cuts, 
as well as an unwillingness of other providers to change the way they practice.  Another 
respondent, engaged himself in previsit planning, echoed the latter sentiment, speaking to the 
difficulty of convincing additional providers to do previsit planning: 
But again you need to realize unfortunately its only when you ask “Has it made an 
impression?” It’s just myself that’s giving you that comment. Because as I said the other 
doctors haven’t participated in a large degree in doing this…When I’ve been away I’ve 
said “Can you help me?” When they’re there they find it worthwhile, but it’s one of those 
things that kind of goes off they’re radar. 
 
One respondent discussed a previsit planning process that did not involve an actual face-to-face 
meeting at all, but was structured around a dedicated “previsit planning sheet,” on which 
pediatric gastroenterology fellows, prior to a visit, can circle whether relevant indicators, such as 
body weight and medication doses, are in the appropriate range.  
Population Management  
 Another significant piece of ICN’s quality improvement intervention is population 
management.  Participating sites enter standardized information for each clinic visit, and this 
information is stored in a collaborative-wide database.  Each month, the collaborative sends 
updated information back to each site in an Excel spreadsheet (called a “population 
management report”) that includes information on every patient enrolled in the database, and 
patients can be sorted by disease activity, nutrition and growth status, as well as the 
medications they are taking.  The collaborative allows sites to identify patients on prednisone or 
infliximab, and several respondents found this useful.   
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 In general, 92% (11 out of 12) respondents from existing sites mentioned population 
management in their interviews, and many respondents spoke of the vast potential of this tool to 
revolutionize patient tracking, especially considering the difficulty of keeping track of patients in-
between clinic visits.  For many patients, communication with their physicians is often infrequent 
and erratic. 25   Especially for chronic disease, having a systematic way to track at-risk patients 
can help fill the gaps between visits.  One respondent felt especially strongly how the population 
management reports help target these patients:  
I think…kids who are doing well, or kids that have really have compliant parents, or the 
kids that are doing really badly, usually come to our attention a lot more quickly, because 
we see them.  But it’s the kids that are doing okay, but may or may not have the most 
compliant families, that I think collaboratives like this help us sort of remember to target 
the follow up so that they don’t fall through the cracks.  (emphasis added) 
Among the sites and respondents we spoke to, the variability in implementation of population 
management strategies was substantial.  Respondents from all seven existing sites discussed 
some population management reports, but only 3 sites described a standardized process for 
using it.  One respondent gave describes such a process, referring to categorizing his patients 
through the population management reports as “audits:” 
Like we would take our monthly report and look at all the patients who had moderate to 
severe disease, pull their charts and make sure that there was an active plan in place to 
try and move them from moderately to severe disease to either remission or at least mild 
disease 
A central theme was that respondents, especially physician respondents, have had very high 
expectations for the population management report, expectations that frequently have not been 
met.  And for several of the existing sites we interviewed, the process of translating pooled 
patient information into targeted site-specific quality improvement interventions has been 
painfully slow.  Physician leaders from three existing sites specifically noted a lack of 
satisfaction with their own use of the tool, up to this point.  Certainly a component of this has 
been an evolving mindset regarding how to best use patient data to make improvements, 
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especially for the majority of sites with less quality improvement experience.  One respondent 
spoke to the difficulty of deciding what changes to make based on the monthly reports: 
The lag time would be that we only recently, only fairly recently, actively used them as a 
basis for discussion for patient management and to reach out to providers… it took us a 
little bit of time to figure out how we wanted to approach utilization of the [population 
management reports] 
In addition, information on patients in the population management reports is only as 
comprehensive as the strategy used to obtain it.  Participation of additional care providers in this 
process entails additional time and effort to complete the required data entry (distinct and in 
addition to clinical information obtained during a clinic visit) that many other care providers view 
as a “burden,” especially at the beginning of the process, according to one respondent.  In 
addition, one respondent described having to re-educate a physician who was not providing 
complete data on patients seen in the clinic.  Difficulty in changing the habits of other providers, 
combined with the current lack of a standardized way to ensure complete data are being 
entered, remain obstacles, according to our interviews. 
Standardized Clinic Templates and Collaborative Interactions 
 Many of our interviewees felt that a variety of shared templates and forms play a 
significant role in quality improvement at their site.  Respondents from 5 out of 7 existing sites 
(71%) mentioned clinic forms as important elements of IBD care at their sites.  Respondents 
perceived these templates as being almost universally successful, for a couple distinct reasons.  
First, several respondents felt that sharing of useful and clinically useful templates on the 
extranet allowed them to avoid making the same mistakes through their own de novo 
development process.  Second, peer interactions, sharing, and teamwork aspects were thought 
to be a major motivating factor for joining a quality improvement collaborative, and these were 
specifically addressed by a majority (56%) of respondents during their interviews.  A theme that 
emerged from addressing standardized clinic forms was that not only did these forms improve 
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the completeness of data-gathering, but also addressed a need for busy practitioners: …”To try 
to maintain uniformity in the evaluation and care of these patients, among providers, and 
between institutions,” in the words of one interviewee.  
 It is difficult to measure the benefit that sites are able to glean from one another through 
different interactive activities (e.g., learning sessions, sharing through the extranet, informal 
conversations with peers) but it is certain that many respondents felt positively about these 
interactions.   The heterogeneity in how different sites attmept to improve care, through site-
specific PDSAs and practice level improvements, allows potentially all sites to benefit from one 
successful effort.  If a site can incorporate psychology support into care for their IBD patients, 
another site can learn how departmental or bureaucratic obstacles were overcome to make it a 
reality.  If a site develops an innovative method for systematically evaluating monthly population 
management reports, another site can adapt a similar model. 
 Since different sites engage in specific PDSAs, and the vast majority of investigators are 
motivated to improve care, the possible successes that sites can have increase as the 
collaborative expands.   For several respondents, actually sharing useful templates via the 
collaborative extranet represented the best way for less-advanced sites to apply discoveries 
from more-advanced sites.  One respondent described these benefits: 
I guess I would simply say this, I think part of the benefit of a collaborative is personal 
contact. I think that being involved in the process, being involved with other 
people…significantly helps the process move forward.  I think it’s way more than additive; 
sort of a geometric increase. And so I think [that] when you go through quality 
improvement you cannot understate the value of interpersonal contact. 
  
Decision Support 
 The ImproveCareNow collaborative has created several important decision aids to help 
standardize and streamline clinical care of IBD patients.  As described by our interview 
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respondents, these include a nutrition algorithm, model care guidelines, and consistent methods 
for recording the five components of the “diagnosis bundle,” (BMI, growth status, disease 
severity, disease phenotype, and nutritional status).   The nutrition algorithm groups patients 
into 3 categories (“satisfactory,” “at-risk,” or “in failure”).  Nutrition and growth status in theory 
can serve as a proxy for disease activity, since chronic inflammatory conditions, if poorly 
controlled, often cause children to fall off of their age-appropriate appropriate growth curves.  
Several respondents mentioned how little controversy there was surrounding the 
implementation of this measure, and similarly described the high expectations sites had for this 
intervention.  Every respondent who commented in detail on the nutrition algorithms has found 
them to be successful, despite the already high expectations.   
 At the same time, proper use of the nutrition algorithm depends on reliably collecting the 
pieces of information that determine the category into which a patient falls, and while many sites 
praised the ability to reliably collect this data now, a not-so-subtle theme underlying 
respondents’ comments was that before the collaborative, considerable variation precluded 
being able to reliably use a nutrition algorithm.  This sentiment was echoed by respondents from 
new sites, one of which plainly noted the absence of a systematic way for tracking how often 
important processes of care like these are followed.  Currently, however, ImproveCareNow has 
clear process-of-care targets for existing sites, designed to increase the consistency of data 
collection, with “key drivers” necessary to reach those targets.  One respondent commented that 
implementation of electronic medical records was particularly helpful for ensuring that growth 
status, BMI, disease severity, etc. are documented every visit, simply because blank boxes on 
the electronic form prompt the physician to ask appropriate questions.  Another respondent 
discussed a protocol through which all new patients are referred to the nutritionist for evaluation, 
a process that has become fairly well standardized at their site.   
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Self-Management Support 
 Self-management is both established component of chronic disease care but also has 
been a frequent component of previous chronic care collaboratives.  .  In general, half (6 out of 
12) respondents from new sites mentioned self-management as an important component of IBD 
quality improvement.  For ImproveCareNow, respondents did not speak of strict requirements or 
guidelines regarding self-management, but many sites spoke of different approach each has 
taken to this end, including educational sessions and psychosocial support groups for patients.  
Accordingly, the approaches taken by different sites have been varied.  One site distributes an 
educational DVD about Inflammatory Bowel Disease to curious and motivated parents.  Another 
respondent discussed adding features such as a patient education day and a parent advocacy 
group, the former of which was adapted from another collaborative site: 
And a couple of the centers had an organized patient education day. And while we have tried to 
do patient support groups in the past, it never really worked out well…this is one we stole directly 
from other people. Proudly. 
Interestingly, the origins for this patient education day came out as a result of presentations 
given at a learning session.  Having previously tried and failed to successfully implement a 
patient education day, this respondent took new ideas from these presentations, and 
constructed a new patient education day that has been more successful.  Other sites have been 
working together more recently to put together an educational workbook  
Effect of the Collaborative 
 In all, 9 out of 12 of interviewees from existing sites felt that improvements were due to 
the collaborative.  In general, supporters felt that reporting data to a centralized database 
helped hold sites accountable for the care that they give.  In addition, interviewees felt that 
paying attention to detail and learning about quality improvement strategies were tangible 
benefits of participation in collaborative activities.  These supporters seemed to imply that the 
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ICN provided the tracking capabilities, standardization of process, and self-management 
strategies, all of which are central components of the chronic care model.26    When asked for 
other potential explanations for the increased remission rate seen in the collaborative, 
responses varied.  Three of twelve respondents at existing sites clearly thought ICN was 100% 
responsible for the outcomes improvement reported by the collaborative.  Among the rest of the 
respondents, three important issues were discussed. Two respondents pointed out that during 
the course of the collaborative, physicians have begun to move to more powerful medications 
early in disease course.  This suggests that scientific or pharmaceutical improvements, or 
possibly prescribing habits themselves, could be partially responsible for the increased 
remission rates.  Another respondent raised the issue of standardization of the disease 
measure.  The Physician Global Assessment (PGA) is the current scale for determining if a 
patient is in remission o r has mild, moderate, or severe disease.  This scale has a subjective 
component, and formal methods for rating the severity of disease have not been a part of this 
collaborative.  Lack of standardization of this instrument could be biasing results.  Another 
variable is the lack of standardization of patient entry into the ICN database.  There is currently 
no way to know if there are systematic differences between patients who are enrolled in the 
database and those who are not.  The motivation to increase the fraction of patients in 
remission, especially among lower performing sites, could play some role in enrolling patients.   
 
DISCUSSION 
 This paper describes a quality improvement collaborative that implemented many 
practice-level changes.  Previsit planning and clinical information systems improvements are 
common components of similar collaborative interventions, and this has been reported in 
qualitative analyses done previously.23, 24, 27-29   However, this study describes the perceptions 
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and activities of sites participating in a collaborative that is much more longitudinal in nature 
than many organizations designed around the Breakthrough Series model, which originally was 
designed to achieve meaningful change in 12 months.7   
 Our results show that collaborative participants value many of the system-wide features 
implemented by their sites.  However, sites have had differential paths to implementation of 
certain core features of the collaborative, and at some sites important feature are under-
developed or under-utilized.  With previsit planning, for example, perceptions and practices 
among physician leaders varied, as some individuals met regularly and discussed upcoming 
patients, while others did not meet at all, but relied on mid-level providers to lead the sessions.  
Since the actual development and implementation of this process seemed to be left up to sites, 
obstacles to implementation including physician and staff numbers and time may prevent further 
evolution of this process at some sites.   
 The self-selection process for participation in ICN eliminates some obstacles that have 
been experienced by teams engaged in quality improvement in the past.  Two notable obstacles 
discussed in related series include knowledge of change structures and strategies and lack of 
physician engagement.  With ICN, physician leaders are inherently motivated, to do QI or 
participate in ICN or both. In many cases, the motivation to join the collaborative may be 
individual rather than institutional, strong leadership is a well-known feature of quality 
improvement interventions.29, 30   In addition, requiring sites to pay yearly dues may make 
participating individuals more motivated to pursue change.28   In addition, motivation to engage 
in quality improvement is abundant among collaborative participants, and learning session 
attendance In a way, encouraging small tests of change, enables participants to see successes 
when they occur, and share them with others.  The role of peers as both students and teachers 
of quality improvement was clearly evident at the learning session, and peer-to-peer spread of 
this nature 28  could be integral in sustaining change.   
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One aspect that seems to have potential for future success is population management.  
The literature on clinical information systems for chronic disease unequivocally backs registry 
and database support as critical for improved outcomes. 31, 32    Allowing physicians to 
categorize patients based on disease severity, their last visit, and other factors minimizes loss to 
follow-up and helps sites target at-risk populations, as many interviewees reported.  At the same 
time, construction of a new tool that allows practitioners to track all their patients has been a 
lofty but often unattainable goal in collaborative interventions.24   Developed specifically for the 
purposes of this collaborative, the database has identified worthwhile targets and outcomes 
relevant for the patient population.  At the same time, duplicity in data entry remains an obstacle 
to continued success of this instrument.  Sites without the ability to hire personnel for data entry 
will be necessarily limited in the information their report will generate.  In addition, some sites do 
not have the necessary time or resources to design targeted interventions based on the report, 
even if data entry is complete.   These issues remain problematic for the collaborative as a 
whole, and for individual sites as well.    
 
CONCLUSION 
In conclusion, collaborative participants have made many important changes to their 
practice to encourage quality improvement, and the benefits are being seen across the board, 
from processes of care to outcomes.  Data gathering, an essential element of quality 
improvement in both manufacturing and health care, has allowed site investigators to target 
specific areas for improvement, and small tests of change have both encouraged continued 
improvements and helped participants experience quality improvement in a more hands-on way. 
 Some additional information could be a part of the population management report.  This 
could include: what percent of children have required surgery and what percent are on certain 
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other medications, so that then the comparability of patients at different sites can be further 
assessed.  Effort and motivation are very difficult to quantify statistically, but from what 
respondents have said and what we have seen, many sites seem to be encouraged to change 
and motivated to do so.  Self-selection of sites for participation in the collaborative means that 
The physician global assessment may not be ideally standardized to evaluate if a true increase 
in remission rates is occurring, and recently a more objective CDAI (Crohn’s Disease Activity 
Index) was developed to address some of these concerns.  Another issue is how patients are 
enrolled in the collaborative.  Early on, sicker patients are more likely to be enrolled, since they 
are seen more often than patients who are well.  Early in the collaborative, there was no 
guideline addressing how often patients should be seen, so it is possible that some healthy 
patients were not seen for many months, which would bias later remission rates positively.   
There are many competing explanations for why the outcomes of IBD patients have 
improved during this collaborative.  We have designed a survey that will assess many aspects 
of the themes we have uncovered here, in a more quantitative fashion.  We hope to have a 
deeper and more representative set of findings once we have collected and analyzed this data.   
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Table 2: ICN Activities & Description 
ICN Activities Description 
Population management An interactive program of patient tracking that allows providers to 
examine care provided to each site’s IBD population across various 
multiple categories, such as disease severity, nutritional status, and 
treatment with selected medications 
Pre-visit planning Process to identify upcoming patient visits and to plan those visits 
before the patient arrives 
Standardized clinic template Standardized clinic flow sheets that allow the physician to 
accomplish a set of goals at a clinic visit 
Nutrition and growth 
algorithm* 
An algorithm developed to assess nutrition and growth status at 
each patient visit and improve the management of patients with 
unsatisfactory results.  
IBD Clinic Implementation of a weekly, bi-weekly, or monthly clinic in which 
only patients with IBD are seen 
Multidisciplinary team meeting Team meetings made up of providers from various disciplines to 
discuss IBD patients. Often includes a physician, nurse practitioner, 
nurse, dietitian, and others. 
PDSA cycles Small tests of change particular to each site based on the Plan-Do-
Study-Act model 
Self-management* Tools in the form of workbooks, seminars, CDs or DVDs provided to 
patients and parents to increase their knowledge of IBD and 
encourage greater disease management and medication adherence. 
Model IBD Care Guideline* Guideline developed to standardize diagnosis, disease monitoring, 
and treatment based on evidence and expert consensus 
 
 
 
 
Table 3:  Kappa Statistics  
Question Kappa 
Q1 – General Impression 0.57 
Q2 – Most Valuable Aspect of Participation 0.83 
Q3 – ICN Activity Categorization 0.82 
Q4 – Outcomes Due to Collaborative 1.00 
Q5 – Potential Confounders 0.62 
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* Includes a site that at the time of the interview had failed to receive adequate funding for a dedicated 
IBD clinic 
 
 
 
 
   19 
Appendix 1: Further Background on Quality Improvement Collaboratives 
 
Origin of Quality Improvement Collaboratives 
 Promotion of quality assurance in the health care field originated long before the IOM 
reports To Err is Human33  and Crossing the Quality Chasm.5  In 1989, Berwick proposed the 
adoption of The Theory of Continuous Improvement in the field of health care.34  However, for 
years few practitioners took quality improvement seriously because, as Kilo explains, promoters 
of quality assurance focused on cost control, did not know how to motivate physicians, had 
unrealistic expectations of health outcomes, and poorly understood the science of 
improvement.7   
Nonetheless, Berwick’s goals for improvement in health care35  were the basis for the 
development of the Institute of Healthcare Improvement’s (IHI) Breakthrough Series (BTS) 
collaborative model in 1998, which aimed to achieve “unprecedented levels of improved 
performance in participating organizations in less than 1 year by bringing providers together to 
understand and drive improvement within a specific topic area” (p. 2).7  The IHI developed the 
collaborative model based on the following principles: 
1. A sustained gap exists between knowledge and practice in health care; 
2. Broad variation in practice is pervasive; 
3. Examples of improved practices and outcomes exist, but they need to be described 
and disseminated to other organizations; 
4. Collaboration between professionals working toward clear aims enables 
improvement; 
5. Health care outcomes are the results of processes; and 
6. Understanding the science of rapid cycle improvement can accelerate demonstrable 
improvement.7  
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The IHI BTS collaborative model offered a framework adaptable for many types of 
diseases, provider networks, and health organizations. Wilson, Berwick, and Clearly 28  
summarized the steps in the BTS Collaborative Model, which are presented in Figure A-1. The 
success or failure of collaborative is dependent on team member interactions, which take place 
during “learning sessions.” Operating under a Plan-Do-Study-Act model, team members learn 
improvement techniques, exchange ideas and advice, and generate enthusiasm and 
commitment to achieving a common goal”36  Learning sessions commonly involve specific 
instruction on improving selected aspects of care, developing, sharing, and refining data 
collection and tracking modalities, and reporting results or recent changes at each site.37   After 
each learning session, team members return to their practice or organization to apply new 
knowledge and evaluate new outcome measures.7  In between learning sessions, access to a 
listserv37  or extranet is common, as are monthly conference calls.  Some collaboratives also 
develop and utilize state- and region-based support, offering technical assistance to 
participating health centers.38    Figure A-2 illustrates the basic framework of the BTS model. 
Figure A-1 
Steps in the Breakthrough Series Collaborative Model 
1. Sponsoring organization identifies topics where a significant gap exists between best 
and typical practice. 
2. The Institute for Healthcare Improvement (IHI) then assembles an expert panel. 
3. Expert panel prepares a package of ideas for closing the gap. 
4. IHI recruits participating teams to be part of the collaborative. 
5. Participants engage in prework: forming a local improvement team, develop goals 
and measurements, and characterize current practice. 
6. During a collaborative’s life, usually 6-12 months, teams from participating 
organizations attend three learning sessions in which they learn about ideas for 
better practice and improvement methods that they implement between sessions. 
7. Between learning sessions, teams share experiences and maintain contact through 
such mechanisms as conference calls and internet email listservs while submitting 
progress reports. 
8. The lessons learned are spread through a national meeting (congress) and reports. 
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Source: Wilson T, Berwick DM, Cleary P. What do collaborative improvement projects do? experience 
from seven countries. Joint Commission Journal on Quality and Patient Safety. 2004;30(Supplement 
1):25-33. 
 
Figure A-2:  The Breakthrough Series Model 
 
LS: Learning session 
 
Source: Kilo CM. A framework for collaborative improvement: Lessons from the institute for healthcare 
improvement's breakthrough series. Quality Management in Healthcare. 1998;6(4):1.  
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Appendix 2: Limited Systematic Review of Quality Improvement Collaboratives 
Introduction 
 Investigators have identified deficiencies in the safety and quality of health care provided 
in the U.S. 5, 33  Among recommendations proposed by the Institute of Medicine’s Crossing the 
Quality Chasm is one promoting collaboration among clinicians, institutions, and patients 
through shared knowledge, free flow of information, evidence based decision making, and 
transparency of health system processes.5  In addition, financial rewards linked with clinical 
outcomes further incentivize adoption of quality improvement methods.39  Quality improvement 
collaboratives (QICs) represent one systems-based approach to improve health care quality and 
patient outcomes.  
 The purpose of this review is to provide an overview of the literature surrounding QICs, 
to classify the types of analyses performed on chronic disease QICs, and to appraise the quality 
of literature examining their effectiveness.  First, we will briefly describe the evidence base for 
QICs. Then, we will report the methods, results, and discussion of a systematic review of 
studies examining collaboratives specifically focusing on chronic disease. Finally, we will outline 
suggestions for future research.  
 
Evaluation of the Evidence Base Surrounding QICs 
Since the inception of IHI’s BTS collaborative model, various health care systems, 
organizations, and groups of providers have adopted versions of collaboratives to fit their needs. 
Improving surgical and critical care outcomes in hospitals were among the first targets of 
collaboratives. Early quality improvement collaboratives included the Northern New England 
Cardiovascular Disease Study Group,40  the US Veterans’ Affairs National Surgical Quality 
Improvement Program,41  and the Vermont Oxford Network,42  which aimed to improve hospital 
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mortality associated with coronary artery bypass graft surgery, morbidity and mortality rates 
after major surgery, and quality of care for very low birth weight infants neonatology survival 
rates, respectively.  
Utilization of collaboratives quickly expanded from hospital-based outcomes to 
outpatient-based diseases and illnesses. As of 2003, the IHI had conducted collaboratives with 
over 700 teams working on 23 clinical conditions.37  In addition, the U.S. Health Resources and 
Services Administration43  and the Veterans Health Administration44  adopted the QIC method. 
Moreover, adoption of collaboratives expanded beyond the Unites States. Australia, France, the 
Netherlands, Norway, Sweden, and the United Kingdom’s National Health Services have 
developed and implemented variations of collaborative programs.28   
Numerous studies document the effectiveness of particular quality improvement 
collaboratives (QICs). Investigators credit the implementation of QICs for reduced inpatient 
mortality rates associated with coronary artery bypass graft procedures,40  decreased neonatal 
infection rates,45  decreased c-section rates,46  less costly prescriptive practices,9  improved 
patient safety,9  decreased emergency department waiting times,47  and improved management 
of patients with chronic disease.9 8  Such studies support the use of quality improvement 
collaboratives as a viable method for identifying and implementing best practices.  
Few studies in the literature conclude that QICs are ineffective, but Landon and 
colleagues37  offer one example. They performed a prospective matched pre- and post-
interventions study of almost 10,000 HIV-infected patients and found that a multi-institutional 
quality improvement collaborative did not significantly affect the quality of care.37  
Other studies sought to identify and explain components of successful collaboratives, 
which often take the form of informant interviews. Ayers and colleagues30  used open-ended 
questions of 18 key informants involved in successful data-driven quality improvement learning 
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collaboratives in the U.S. and Europe. They identified the following patterns:  cultivating trust, 
attendance to the human dimension, nonlinear development, attendance to organizational 
culture, integrated philosophy of quality improvement, and a focus on process and outcome 
measurement to drive change.30  Meanwhile, Wilson and colleagues28  performed semi-
structured interviews with 15 leaders of collaboratives to ascertain the features of effective 
collaboratives; they identified the following seven critical determinants: sponsorship, topic, ideas 
for improvements, participants, senior leadership support, preliminary work and learning, and 
strategies for learning about and making improvements.28  However, the internal validity of these 
studies is questionable because of variation in collaborative frameworks, which targeted a 
diverse set of medical outcomes and settings, ranging from ambulatory care to critical care 
units. Similar inconsistencies are rampant in the QIC literature. 
 
Methods 
 We conducted a MEDLINE search to search for literature written about chronic disease 
QICs published before January 2010. The search algorithm appears in Figure A-3. We used the 
following MeSH terms: “quality” AND (“cooperative behavior” OR “cooperative” AND “behavior” 
OR “collaborative”) AND “improvement.” Our 2-person team reviewed the titles and abstracts of 
articles appearing before January 9, 2010. To obtain additional articles not recovered in our 
MEDLINE search, we hand-searched references of sentinel articles. 
We included studies that were written in English, took place in the U.S., examined 
collaboratives targeted at one or more chronic diseases, and met the definition of collaborative.  
In an ad hoc manner we defined a quality improvement collaborative (QIC) as “a voluntary 
network of health care providers in more than one health care system, who agree to share data 
and information on processes of care for the purpose of improving the quality of care and 
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patient outcomes.”  This definition was based on a pilot search and review, which identified 
important components of these interventions as including identification of variations in care or 
deviations from published guidelines, defined, measurable outcomes, a willingness to pursue 
active information sharing, and collection of data with the intent to study the effectiveness of the 
intervention.  These variables, and others, were also identified in a systematic review of 
collaboratives by Schouten et al, which helped add a measure of validity to our original search 
goals and inclusion criteria, for quality improvement collaboratives.48    
We excluded articles if the collaboratives took place in the settings of improvement in 
emergency departments, intensive care units, and primary care practices not focusing on a 
particular chronic disease. We also excluded articles written about collaboratives focused on 
organ donation, general preventive measures, medical imaging, surgical interventions, and 
palliative care.  
From abstracts and full-texts of the articles meeting inclusion and exclusion criteria, we 
extracted the following information: the authors and year of the publication, the disease or 
medical specialty (i.e. pediatric cardiology, psychiatry, etc.) addressed in the collaborative, the 
setting of the collaborative participants, and the type of analysis performed by authors. We then 
classified the types of analyses into the following three broader categories: process and 
methods, sustainability, and effectiveness. Process and methods included articles written about 
the need, development, and implementation of quality improvement collaboratives. The 
category of sustainability included articles that described or identified internal or external 
resources necessary to sustain the effects of a collaborative.  Among these, we also recorded if 
authors addressed the importance of team work or informatics as necessary components of the 
collaborative investigated. Finally, the category of effectiveness included articles that evaluated 
the effectiveness of collaboratives on patient outcomes.   
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Next, we appraised the quality of studies measuring the effectiveness of QICs. We 
reviewed the articles classified in the category of effectiveness for studies reporting patient-
oriented outcomes. We excluded studies evaluating effective components of a collaborative, i.e. 
teamwork or information technology, and studies examining exclusively non-disease specific 
outcomes. From the studies meeting these inclusion and exclusion criteria, we extracted the 
following information: the disease or medical condition addressed by the collaborative, a brief 
description of the study, the study design, the participants in the analysis, the source of 
assessment, the outcomes assessed, the methodological status, the duration of follow-up, and 
the findings. For each study, we appraised the internal validity, external validity, and the clinical 
utility of the measured outcomes.   
Results 
 The MEDLINE search algorithm produced a total of 626 articles, but only 51 met 
inclusion criteria. A hand-search of pertinent literature yielded five additional articles. Table A-1 
details the classification of the 56 articles. Nineteen fell into the category of process/methods, 
15 in sustainability, and 22 in effectiveness.  
Categories of Literature 
Process/methods articles focused principally on the formation and evolution of the 
development of collaboratives. If collaboratives were new to a particular medical field, such as 
pediatric cardiology or pediatric gastroenterology, investigators published articles outlining the 
need for a QIC and often detailed an adapted model to suit the goals and needs of the field. 
Other process/methods articles focused on the implementation of a collaborative or evaluated 
the implementation by measuring clinic or physician practices. 
Articles classified under the categories of sustainability and effectiveness reported 
various outcomes about collaboratives that had been in operation for at least one year. In 
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general, sustainability articles reported the necessary components to sustain the quality 
improvement practices initiated because of a collaborative. Some investigators addressed 
sustainability of a collaborative itself, while others focused on specific components of the QIC. 
To evaluate which components of a QIC were effective, investigators often conducted 
qualitative methods, such as interviews with key informants. Six sustainability studies31, 49-53 54  
mention information technology as a necessary component, while 431, 49-51  of these specifically 
evaluate a particular type of technology utilized in the collaborative. Three sustainability 
studies53-55  cited an element of teamwork as an effective QIC component. One study evaluates 
the cost-effectiveness of implementation of a QIC.  
Investigators evaluated a variety of outcomes of collaboratives in studies classified in the 
category of effectiveness. The outcomes examined are as diverse as the goals for initiation of 
collaboratives. For instance, some QICs aim to reduce disparities among diabetic patients, while 
others evaluate physician practices and patient-outcomes.  
Unsurprisingly, most collaboratives address common health conditions, such as heart 
failure, diabetes mellitus, asthma, and depression. QICs focused on HIV and stroke were also 
common. Unique medical topics included urology and COPD. Pediatric illnesses were also 
represented in the chronic disease QIC literature. Common pediatric conditions or topics 
addressed included asthma, inflammatory bowel disease, development disorders, cardiology, 
and rheumatology. 
Critical Appraisal 
 A summary of the systematic review of QIC effectiveness studies is provided in Table A-
2. Overall, 13 manuscripts met the inclusion criteria for the systematic review of the 
effectiveness of QICs. 37, 38, 56-60, 60-66   Of these, only 3 studies involved a randomized component 
in their study design.  Five included studies 37, 38, 56, 57, 63  used a comparison group study design, 
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with selected intervention sites and control sites, not unlike a case-control design.  Three 
studies59, 60, 63, 65 used quasi-experimental before-and-after designs, one66  used a cross-
sectional analysis of a state’s health plans, and two studies58, 61  were uncontrolled cross-
sectional analyses of a single site participating in a collaborative intervention.66   
 
Randomized Studies 
Two of the studies featuring a randomized component62, 64  used a cluster randomized 
controlled trial design, randomizing at the practice level to assess the intervention.  One study60  
was designed primarily as a quasi-experimental before-and-after design, but randomized 
selected centers to either standard or high-intensity collaborative interventions (the latter 
involving four additional learning sessions and additional provider training).  On the whole, none 
of these randomized trials or arms found that collaborative quality improvement interventions led 
to improved outcomes.60, 62, 64  One study62  randomized forty-three practices in greater Detroit, 
Mich and greater Boston, Mass to participation in a learning collaborative based on 
Breakthrough Series methodology or standard care.  For children with asthma, Homer et al 
found no significant improvements in asthma process-of-care outcomes, clinical outcomes, or 
utilization outcomes for individuals randomized to the intervention group.62  Another randomized 
study64 , undertaken by Philbin et al, randomized ten hospitals in the upstate New York.  
Intervention hospitals received an intensive, multifaceted quality improvement intervention 
consisting of educational sessions, critical pathways, and lectures.  The New York research 
team found no significant improvements in process-of-care markers or clinical outcomes among 
intervention sites compared to controls.  However, a slight, non-significant reduction in hospital 
length-of-stay was observed among intervention hospitals.  The third and final study with a 
randomized component that fit our inclusion criteria was a study of a diabetes quality 
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improvement collaborative, undertaken by Chin et al.60  Embedded in a longitudinal study 
looking at the effect of a collaborative quality improvement intervention for, sites treating 
patients with Type 2 diabetes were randomized to either a high-intensity and standard protocol 
after 1-2 years of participation.  For ACE inhibitor and aspirin use, Chin et al found slightly 
higher documented rates of compliance.60  However, for many other intermediate incomes, and 
for clinical outcomes measures, there was no significant effect of the higher-intensity 
intervention.60  For several of the intermediate outcomes, including HbA1c levels and systolic 
blood pressure measurements, control sites out-performed sites that participated in the high-
intensity intervention. 
Observational Studies 
The majority of the studies included in our review were observational studies, employing 
several different designs.  The preponderance of observational study designs among our 
included studies mirrors the predominance of non intervention-based, observational studies in 
the literature on collaboratives.  Four studies 37, 38, 56, 57  that met inclusion criteria for our report 
were observational studies molded as case-control studies at the practice level.  These studies, 
offering fewer statistical limitations and theoretically fewer potential confounders and biases in 
their study design than simple before-and-after studies, represented the most common type of 
study included in our report.  Asch et al studied the effects of a BTS collaborative heart failure 
outcomes, finding a significant positive effect of collaboratives on counseling and education 
outcomes, as well as positive effects on rates of ACE inhibitor and lipid-lowering therapy for 
heart failure patients.  However, Asch et al found no improvement in readmission rates for 
patients at participating sites.56   Landon et al, in 2004, published results from a similar 
assessment of a BTS collaborative, this time concerning HIV treatment and quality.  Comparing 
44 intervention sites to 25 control clinics primarily on the basis of control of viral load and 
prevention of opportunistic infections, investigators found no significant differences in outcomes 
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between the two groups.  Although the end result was a lack of significance, the proportion of 
patients with viral load controlled increased twice as much in the intervention group compared to 
the control group; these figures were 11.0% improvement (40.7 to 51.7) and 5.4% improvement 
(44.1 to 49.5), respectively.37  
Despite mediocre results in the EQHIV study, another Landon-led research team 
assessed the effects of collaboratives on management and outcomes of asthma, diabetes, and 
hypertension.38   Interestingly, for these common chronic diseases, Landon et al found that 
collaborative participation was associated with improvements in screening, prevention, and 
disease monitoring, for patients with asthma and diabetes.38   Similar improvements were not 
seen with hypertension, however.  For diabetes and hypertension, there was virtually no effect 
of collaboratives on clinical outcomes, however.  In contrast to these results, Baker et al found 
that participation in a collaborative for heart failure reported much higher quality of life, 
satisfaction with medical care, and knowledge of their condition.57   Most importantly, patients in 
the intervention group utilized less care, in terms of hospitalizations, than those in the control 
group.57   Despite selection concerns in this study, the utilization outcomes data shows that 
meaningful improvement likely did occur.  The final study comparing “intervention” sites to 
selected control sites assessed the effects of a quality improvement collaborative on quality of 
care and outcomes for childhood asthma. 63   Comparing nine intervention sites with four control 
sites, Mangione-Smith et al found significant improvements in process-of-care measures and 
patient self-management skills.  However, small differences in health utilization outcomes 
between the two groups were not statistically significant, echoing the non-significant findings of 
this type in several other studies.38, 65     
Of the remaining studies that fit our inclusion criteria, three employed a before-and-after 
design, one analyzed variations in care from the perspective of a state health plan, and two 
studies were uncontrolled studies, reporting results and experiences related to a single site’s 
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participation in a collaborative.  Two of the before-after studies targeted Health Disparities 
Collaboratives (HDCs).  Both of these 59, 60  studied the effect of collaborative interventions on 
diabetes care, using a collaborative structure that emphasized involvement of community health 
centers, combining semi-structured interview data with surveys and reviews of medical records.  
In these studies, investigators found significant improvements across the board, from process-
of-care measures such as HbA1c checks, foot and eye exam referrals, and lipid assessments, 
as well as HbA1c control, an intermediate outcome that for diabetes serves as a monitor for 
disease control.  Between the two studies the improvement in HbA1c ranged from 0.2%59 to 
0.45%60 , although this difference was not significant in either case.  The third study with a 
before-after study design65  actually included control sites for comparison, but the control sites 
had dramatic differences in location and payer mix compared to intervention sites, so for the 
purposes of this analysis the study was treated as a time series analysis.  Schonlau et al found 
several significant differences between intervention clinics and control clinics, including several 
satisfaction and self-management indicators.65   With only 9 included centers, however, the 
number of utilization outcomes or events (e.g., emergency room visits) was very small, 
preventing investigators or readers from reaching meaningful conclusions from the results.  For 
example, during the 13 month period of the study, in the intervention group there were 2 
emergency visits by patients during the study (according to survey data), compared to a single 
ED visit among control patients.65  
One study66  that met our inclusion criteria found positive gains attributed to a statewide 
collaborative for Diabetes quality improvement.  Reported from the perspective of Wisconsin-
based HMO health plans, Siomos et al found incremental improvements in LDL and HbA1c 
monitoring, nephropathy screening, and eye exam referrals.  However, absent in this study were 
descriptions of which HMO plans were included for each year of analysis as it varied according 
to year, and was not explicitly tracked.  Nor was there included information on selection of sites, 
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clear presentation of results, or analysis of findings.  The final two studies that met our search 
criteria58, 61   had similar validity questions, stemming from incomplete and haphazard reporting 
of results, no arrangements or discussion of secular trends, and lack of demographic 
information on included patients or sites.  In addition, Benedetti et al and Fox et al presented 
select information on only one participating center, which drastically limits the validity of these 
studies.   With no substantive discussion of secular trends, the primary purpose of these studies 
was informative.  From an appraisal standpoint, however, these two studies do little to prove 
that quality improvement collaboratives have a positive, meaningful effect on quality of care and 
outcomes. 
Discussion 
 The literature on chronic disease QICs is appropriately diverse to coincide with the 
variety of chronic diseases and conditions and the range of goals QICs seek to address. For 
instance, the heterogeneity of HIV patients seen at outpatient care facilities may require 
completely different management strategies from visit to visit. Thus, an HIV collaborative may 
be less fitted to a rigorously systematic, QIC methodology.  
The three categories of process/methods, effectiveness, and sustainability represent the 
natural evolution of QIC literature. Investigators will continue to report adapted QIC processes 
and methods for different conditions. Next, collaborative participants must measure patient 
outcomes and determine what components of the QIC contribute to those outcomes. Finally, 
identifying and developing methods to sustain quality improvement is crucial. The literature thus 
far indicates chronic disease QICs are at an early evolutionary stage. 
In particular, investigators need to measure consistent patient outcomes to strengthen 
the evidence of effectiveness of chronic disease QICs. Doing so requires reliable and valid 
quantitative medical research designs. However, the transition to evaluation of effective QIC 
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components and how to sustain them likely requires qualitative research methods, which may 
be a challenge for clinical investigators unfamiliar with such methods. 
An appraisal of the chronic disease QIC effectiveness literature reflects poor internal 
validity. Randomized controlled trials have the greatest potential to maximize internal validity, 
but they are rare in the literature. We did not find consistent, corroborated evidence proving the 
effectiveness of collaboratives.  
There are several limitations of these studies that both weaken the strength of the 
results and highlight the difficulties inherent in effectiveness research on quality improvement 
collaboratives.  Unfortunately, conducting assessments of practice-based interventions is quite 
difficult, especially for the purposes of directing public policy or solidifying a research base that 
meets commonly referenced reporting standards.  Utilization of non-randomized studies, up to 
this point unofficially, as the primary method for proving the effect of collaboratives on improving 
the quality of care is fraught with hazard.67   Put simply, the greater the concern about the 
methodological quality of some of these studies, the less we know that their results are valid.  
For example, when only a small fraction of sites participating in a collaborative volunteered to be 
studied as intervention sites, there were many ways for that sample to be a non-representative 
one.  Leaders at underperforming sites participating in a collaborative, especially with data 
collection aids, likely were aware of their sites’ relative poor performance, and may not have 
volunteered for a study because of their own inherent belief that collaboratives are beneficial.  
Randomization affords the investigator the opportunity to account for both known and unknown 
confounders, and with special relevance for collaborative-based interventions, has the potential 
to eliminate biases associated with secular trends.  Still, RCTs are not immune to biases, and 
what follows is a discussion of limitations associated with the randomized studies that analyzed 
the effectiveness of collaboratives.   
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 In the study by Homer et al62 , a much higher percentage of patients enrolled in control 
sites were on Medicaid.  In addition, as reported by the study authors, the risk of contamination 
in the study was high.  This arises from the fact that although 43 sites were randomized at the 
start of the study, representing the largest sample of clinics included in our review, all forty-three 
practices were located in one of two geographic areas.  In one of the studied regions (Detroit, 
MI), all of the participating sites, regardless of control or intervention status, were under the 
same ownership.  An unknown dilution factor could have assimilated the medical practice of 
intervention and control sites that happened to employ the same physicians, but the effect this 
had is uncertain.  In addition, there is no way to ascertain the level of participation or 
commitment at each site, given that sites were randomized, and some sites with limited 
investment in the project may have diminished the magnitude of effect at certain sites.   
Another randomized study, undertaken by Philbin et al64 , randomized 10 practices to 
either an intensive quality improvement intervention or standard care, for patients with heart 
failure.  This study was exposed to fewer potential biases than the earlier study, primarily due to 
minimal contamination concerns, but had limitations of its own.  First, blinding was not 
maintained during the study.  In addition, as is the case with the other randomized studies, it is 
difficult to know what effect any secular trends, among the control sites, may have had.  Further, 
as with other randomized study designs analyzing the effect of practice-level interventions, it is 
very difficult to ascertain the intent or strength commitment of participating clinics and their 
leaders and practitioners.  Leadership is an oft-mentioned component of successful quality 
improvement and collaborative interventions.27, 44   Additionally, although Philbin et al made 
heart failure the focus of their study, the primary evaluations were carried out from the 
perspective of acute inpatient diagnosis and treatment, rather than chronic outpatient care.   
The final study that included a randomized component in the study design was 
conducted by Chin et al.60    The randomization to either standard-intensity intervention (with no 
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additional learning sessions) or the high-intensity intervention (attendance at 4 additional 
learning sessions) did not give any significant differences between groups.  However, there are 
several reasons why a true benefit to collaborative interventions might have been missed here.  
First, even though the study used randomization, it is vital to note that randomization occurred 
1-2 years into the study, at which time all included sites had been participating in the 
longitudinal, observational study, attending collaborative learning sessions, and engaging in 
quality improvement measures.60   Thus, a majority of the attainable improvement may have 
already been reached by the time of randomization.{{}}   In addition, as is the case with the vast 
majority of studies on collaborative interventions, documentation variation plays as substantial 
role in the perceived effectiveness of collaboratives, in many of these study designs.  In this 
particular study, the high-intensity intervention was associated with less documentation of 
diabetes education and exercise counseling.{{}}  However, additional attention to medication 
adjustments and communication may have left less time for counseling in a short clinic visit.  Or, 
physicians may have continued with counseling but spent less time documenting so in medical 
charts.  The uncertainty with documentation issues like these clouds a final judgment of 
effectiveness of the high-intensity intervention.   
The longitudinal study published by Chin et al in 200459  as well as the longitudinal study 
(with the embedded randomized component) published in 200760  both are burdened with a 
serious validity concern that affects any before-after study of this type.  Unlike the more 
sophisticated interrupted time series design68  that employ time series regression models to 
reduce unwanted bias in their design, before-after or time-series designs have few defenses 
against the risks of secular trends.  In a health care environment with increasing awareness of 
quality of care and quality improvement, especially since the release of the IOM reports, the 
potential effects of secular trends are substantial.  During observational studies like these, 
unknown and unstudied events can occur at any subset of participating sites, drastically 
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weakening the ability of readers to make causal inferences about their results.68    Internal 
validity can easily be compromised, especially if studies essentially conduct two-sample t-tests 
on pre-intervention points and post-intervention points. Doing so gives inaccurate effect sizes if 
pre-intervention trends are present.68     
Certainly, not all observational should be judged equally.   Achieving improved quality of 
care for HIV patients, as discussed in the EQHIV study37 , in many ways represents a more 
difficult challenge than doing so for patients with chronic cardiovascular disorders, such as 
hypertension or diabetes.  At any particular site in the EQUIV study, especially in a non-
randomized environment, variation in follow-up, medication adherence, and insurance status, 
could conceivably have a larger effect on care outcomes than the actual care received in the 
clinic. Adherence to anti-retroviral medications, for example, is directly correlated to HIV viral 
load, although adherence could be a confounding variable in a non-randomized study.    In 
addition, socio-economic and demographic characteristics of the patient population, clinic 
organizational cultures, and financial and regulatory issues make the task considerably more 
complex.69   Landon et al attempted to account for known confounders by matching intervention 
sites to control sites according to several criteria.  Rigorous observational study designs like the 
EQUIV study can be useful, although currently there is no method for assessing the role of 
leadership at participating sites.  Although it is potentially just as problematic in randomized 
studies, since sites with strong leadership could all be randomized to control sites, the effect of 
a quality improvement “champion” or leader at sites participating in a collaborative is universally 
understood and valued by those with collaborative experience.7, 27   Sites without motivated 
leaders may consistently underachieve compared to centers with strong leadership.  
Unfortunately leadership is difficult to assess in these studies.   
Another problematic issue when analyzing and interpreting the literature on the 
effectiveness of collaboratives is the almost universal reliance on medical records for data 
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collection.  As discussed previously concerning the randomized intervention undertaken by Chin 
et al, this problem drastically undermines the ability to draw conclusions from uncontrolled 
studies58, 61 , in which simply increasing documentation in a practice or practices can give the 
impression that large improvements in care have occurred.  But even for more sophisticated 
studies, determination of statistical significance from medical records alone is troubling.  If, for 
example, a learning session emphasizes preventive counseling and lifestyle changes for heart 
failure, does finding a higher percentage of patients with “dietary counseling” in their chart 
indicate quality improvement?  For evaluation of prevention and screening measures, an 
undocumented test or discussion is one that for the purposes of analysis did not occur.  Further, 
in practice-based intervention studies where blinding is seldom performed, an increased 
emphasis on documentation may falsely create the sense of improvement when the only 
improvement has been documentation itself.57   This apparent effect may be embellished further 
by investigators who, although they have the best of intentions, are invested in collaborative 
methods and intrinsically believe in their value.  Although not a central point in published 
guidelines for reporting observational studies70 , blinded, dual review is a vital component of 
systematic reviews and dual review could potentially be used to increase the validity of these 
types of studies.  Such a measure would not eliminate potential biases that can arise from 
review of medical records, however.   
Still, an important distinction about medical record abstraction should be made here, 
because some endpoints can be reliably taken from medical records.  One of the most 
important uses of medical records is making a determination of definite clinical outcomes, such 
as MI, stroke, death, or other conditions that are easily defined and reliably documented.  
However, of the 14 studies we evaluated that analyzed the effect of collaboratives on chronic 
disease care, only 6 (or 43%) even collected data on clinical outcomes.  Data tables in these 
articles are filled with satisfaction measures, quality of life indices, and process-of-care targets, 
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some of which are linked to improved outcomes.  However, higher indicators now do not equal 
improved outcomes in the future.  Whereas there can be disagreement among scales and 
indices when researchers assemble them together to make a clinical judgment, as in a meta-
analysis, there is no dispute when studies publish hard, easily defined, concrete outcomes.   Of 
course, improving quality of care is not limited to keeping patients alive, and true quality 
includes many of these components.  In addition, the current medical record abstraction method 
for data collection in these practice-level interventions is quite useful for some conditions.   For 
instance, heart failure is a condition that arguably is quite better suited to medical record 
abstraction.  For heart failure patients, unlike patients with other medical conditions, utilization 
outcomes can be used as a proxy measure for disease control.  With diabetes mellitus, the 
pathological processes underlying the disease are often undetectable to afflicted patients, and 
long-term adverse events like heart attacks, strokes, and peripheral vascular complications are 
most commonly measured.  For heart failure, a poorly controlled patient is a symptomatic one, 
who will likely present to the hospital with more short-term needs.   
 
Future Directions 
 Despite the hope that collaboratives do improve care enough to lead to improvements in 
satisfaction, processes of care, and self-management, the evidence linking these changes to 
improvements in patient outcomes is somewhat underwhelming.  With these limitations, 
however, come opportunities for improvement, and there are other indications that 
collaboratives may be more successful than the demonstrated evidence currently indicates.  For 
instance, many collaboratives are currently ongoing.  Although funding constraints and logistical 
issues have prevented long-term data collection and analysis for the purposes of publication, 
these opportunities will increase the future.   
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Although the literature to date contains some methodological flaws, the sense of 
cooperation, information-sharing and camaraderie that these interventions can create, both 
between sites and within sites, is likely already leading to improved care.  In a recent study by 
Bray et al, researchers found that even once a collaborative project with a defined-length of 
operation ended, many of the quality improvement programs, from infrastructure support, 
regular meetings to study patient data, and leadership development, remain in place at 
participating clinics.54    
QICs are likely to become more frequent in pediatrics as the American Academy of 
Pediatrics now requires participation in quality improvement projects.  In the Education in 
Quality Improvement for Pediatric Practice (EQIPP) program, qualified improvement projects 
help distribute practice-wide data on effectiveness and management.71   Enrollment in such a 
program allows one to receive credit that is required under Maintenance-of-Certification 
guidelines for Pediatricians.  Collaboratives may be beneficial to streamline practices, 
implement efficient data management strategies, and improve patient tracking, but they are not 
equally suited to all diseases treated in an outpatient setting.   Investigators and researchers 
must systematically define, through assessments of performance outcomes and medical record 
audits, which disease processes are more amenable to collaborative interventions and which 
are less so. 
 The gaps remaining in the literature must be addressed by subsequent investigators.  As 
mentioned earlier, current medical management of certain chronic diseases is unclear and must 
be defined.  Such a step requires commitment of regulatory agencies and professional medical 
associations alike.  An effort should be made to increase the number of facilities involved in 
these interventions, to strengthen the ability of statistical techniques to show significant 
conclusions.   In addition, an increased number of included clinics, from various geographic, 
socioeconomic, and organizational styles, must be approached and included.   
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Second, key investigators and journal editors must establish standards for research 
design and methods for evaluating collaboratives to ensure reliable, valid, and comparable 
findings, which may facilitate future systematic reviews and meta-analyses.36  Third, sponsoring 
agencies of QICs need to provide more information regarding the teaching and implementation 
of collaboratives.37 37  The IHI BTS collaborative model provides the most detailed information on 
collaborative start-up; however, many variants exist. Additionally, BTS collaboratives were 
designed to last one year or less and offer little direction for providers once a particular 
collaborative is over.  
Finally, quality improvement remains a complex issue in health care. If inconsistent 
research designs prevent the identification of successful components of QICs, then the 
components necessary to sustain quality improvement following the completion of a 
collaborative is less certain. An evidence base for quality improvement itself must be improved. 
Future research must address concepts regarding the nature of quality problems, quality 
improvement processes, and the types of research needed to elucidate these processes.36   
As the push for improved health care processes and patient outcomes continues, quality 
improvement collaboratives present a popular method to develop best practices, which may 
shape future payment systems.  Collaboration between like-minded physicians can increase 
camaraderie, facilitate data, speed the adoption of best practices, and most importantly, 
improve care for patients with chronic disease.  However, the research methods to evaluate 
collaborative interventions require a different mindset, and standards different from those 
required of a drug trial or biochemical assay.  As interventions effecting practices, collaboratives 
are tests of teamwork, leadership, and commitment.   With a renewed emphasis on patient care 
and best practices, the true effect of these QI interventions remains to be seen.  Until then, 
collaborative interventions may represent some of the most ambitious efforts to change 
outpatient care delivery for patients with chronic diseases. 
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Table A-1:  Results of Systematic Review Literature Search 
 
 
Asch, et al. 
Baker, et al. 
Ballard OJ et al 
Benedetti, et al. 
Bonomi AE et al 
Chin MH et al. 
Chin MH et al. 
Cretin S et al. 
Fox J et al 
Homer, et al. 
Johnson EA et al. 
Katzelnick OJ et al. 
Landon BE et al. 
Landon, et al 
Mangione-Smith R et al. 
Meehan TP et al. 
Otley AR et aL 
Philbin EF et al 
Schonlau M et al. 
Siomos EE et al. 
Year Medical Topie/Condition 
Congestive Heart Failure & 
2005 Diabetes Mellitus 
2005 Heart F allure 
2002 Diabetes Mellitus 
2004 Diabetes Mellitus 
Congestive Heart Failure & 
2002 Diabetes Mellitus 
2007 Diabetes Mellitus 
2004 Diabetes Mellitus 
Diabetes, CHF, asthma, 
2004 depression 
2006 Acute Ml & Heart Failure 
2005 Pediatric Asthma 
2005 Diabetes Mellitus 
2005 Depression 
2004 HIV 
2007 Diabetes, Asthma, Hypertension 
2005 Pediatric asthma 
2004 Hypertension 
Pediatric Inflammatory Bowel 
2006 Disease 
2000 Heart Failure 
2005 Asthma 
2005 Diabetes Mellitus 
Stoeckle-Roberts Set al 2006 Stroke 
Swanson KA et al. 
Boratgis G et al 
2007 Depression 
2007 Heart Failure & others 
Pediatric Inflammatory Bowel 
Effectiveness 
Effectiveness 
Effectiveness 
Effectiveness 
Effectiveness 
Effectiveness 
Effectiveness 
Effectiveness 
Effectiveness 
Effectiveness 
Effectiveness 
Effectiveness 
Effectiveness 
Effectiveness 
Effectiveness 
Effectiveness 
Effectiveness 
Effectiveness 
Effectiveness 
4 IHI BTS partic ipating health care organizations & 4 controls 
6 health care organizations partic ipating in an lHI BTS collaborative 
22 primary care practices in a network owned by Baylor Health Care System 
Sites partic ipating in a W ashington state diabetes collaborative 
108 organizational team from across the US active in 1 of 4 IHI O!Cs 
24 health care centers in the Health D1sparit1es Collaborative for 2 years 
19 Midwest health centers 
37 participating organizations, 22 control sites 
5 hospitals in Wichita, KS 
43 chmcs in the greater Detroit & Boston areas 
40 primary care practices in 3 rural states 
20 ethnically & geographically dive rse health care organizations 
44 intervention chnics & 25 matched control clinics 
Community health clinics in the Health Disparities Collaborative 
13 primary care c linics 
17 primary care practices treating Medicare patients 
18 US & Canadian centers 
10 acute care community hospitals in upstate NY 
6 intervention c linics & 3 matched control sites in an asthma collaborative 
Effectiveness Managed care plans participating in state diabetes collaborative 
Effectiveness 13 Michigan hospitals in a stroke collaborative 
Effectiveness Sample of 11 of 108 community-based health care organizations in a national depression collaborative 
Process/Methods 3 collaboratives addressing chronic disease or chronic care 
Bousvaros A et al 2006 Disease Process/Methods NIA 
Britton LF et al. 2008 Pediatric Cystic Fibrosis Process/Methods 1 center of 14 receiving a CF collaborative grant 
Deprez R et al. 2009 COPD Process/Methods 18 primary care c linics in rural Mame 
Fitzgerald E et al. 2005 Psychiatry Process/Methods NJ state mental health serv~ces & psych hospitals 
Jenkins KJ et al. 2008 Pediatric Cardiology Process/Methods Various centers invot\led in pediat ric cardiology collaboratives 
Kristofco RE & NM Loren; 2007 Depression Process/Methods 23 ethnically & geographically diverse health care organizations 
Pediatric Cardiology-Hypoplastic L 
Kugler JD et al 2009 Heart Syndrome Process/Methods Members of the Jo1nt Council on Congenital Heart Disease 
LaBresh KA et al. 2006 Stroke Process/Methods Members of a national stroke registry 
Mandel KE et al. 2007 Pediatric Asthma Process/Methods 44 pediatric practices in an asthm a improvement collaborative 
Mcinnes OK et al. 2007 HIV Process/Methods 54 intervention HIV chnics vs. 37 control clinics 
Moeschler JB et al. 
Newton P J et al. 
Pearson ML et al. 
Rosenman MB et al. 
Ruperta N et al 
Schwamm L et al. 
Siegel B et al. 
Sostman HO et al. 
Bray Pet al. 
Brownson CA et al 
Cole SAet al. 
Davies E et al. 
Oeo S et al. 
Desai J et al 
Fremont AM et al. 
Grant RW et al. 
Green CJ et al 
Hankinson MT et al 
Huang ES, et aL 
Kilbourne AM et al. 
LaBresh KA et al. 
Meyer 8 et al 
Nease DE Jr. et al. 
Pediatric Developmental 
2009 Delay/Intellectual Disability 
2006 Heart F allure 
2005 CHF, OM, depression, asthma 
2006 CHF, OM, asthma 
2004 Pediatric rheumatology 
2006 Stroke 
2009 Heart F allure 
2005 Various 
2009 Chronic Diseases 
2007 Diabetes Mellitus 
Depression & Congestive Heart 
2006 Failure 
2005 Various 
2009 HIV/AIDS 
2003 Diabetes Mellitus 
2006 HIV 
2006 Diabetes 
2006 Chronic Disease Management 
2006 Urology 
2007 Diabetes Mellitus 
2008 Mood Disorders 
2004 Coronary Artery Disease 
2002 Depression 
2008 Depression 
Process/Methods 5 chnical genet1cs practices in Northern New England 
Process/Methods NIA 
Process/Methods 42 organizations in 3 O!Cs 
Process/Methods State-sponsored collaborative made up of PCPs of Medicaid pts 
Process/Methods 2 international networks of pediatric rheumatologists 
Process/Methods NIA 
Process/Methods 2 acute care hospitals in a multi-hospital collaborative 
Process/Methods 2 academic medical centers 
Sustainability 
Sustainability 
Sustainability 
Sustainability 
Sustainability 
Sustainability 
Sustainability 
Sustainabihty 
Sustainability 
Sustainability 
Sustain ability 
Sustainability 
Sustainability 
Sustainability 
Sustainabihty 
13 primary care sites in NC 
20 diverse health care teams across the US in a collaborative 
24 patients in a Northeast large not-for-profit provider health system 
8 medical groups in MN 
Cross-section of Ryan White CARE Act funded c linics 
Primary care clinics in a large MN managed care organization collaborating with the state public health department 
9 VHA chnics 
14 primary care practices in a multi-hospital health care network 
30 community-based physic ian partic ipants 
5 network facilities of the NJ VHA 
17 Midwestern heatth care clinics in the Health Disparrties Collaborative 
Mental health care facility in a VA-academic partnership 
24 MA hospitals 
Psychology clinics at Louisiana State University's Department of Psychology 
26 primary care c linics in a collaborative 
   42 
Table A-2:  Systematic Review Final Inclusions with Quality Ratings 
 
Study reference. Description of Source of 
Addresses 
Clinically 
Interna l External Significant 
year Topic or Condition Study Study Design Participants in Analysis Assessment Outcomes Methodological Status Duration of Follow-Up Findings Validity Validity Outcomes 
Congestil.-e Heart 
Asch. et a1(2005) Failure 
Baker et a1(2005) Heart Failure 
Benedetti et al, 
2004 Diabetes Mellitus 
Baseline measurements 
(presented) Control shes (yes -
Medical minimal discussion of where 
records of control sitescame from) 
Study of 4 sites patients at Standardized outcomes across 
im'Qived with BTS Observational, both 23 quality different sites Protection from 
collaborative for 
chronic heart 
failure 
Study of6 
organizations 
participating in 
BTS quality 
improvement 
collaborative 
Discussion and 
Results from a 
site participating 
companson intervention indicators bias(selection issues most 
cross-sectional 4 IHI BTS organizations, with and control developed for prominent) Protection from 
study 4controls CHF secular changes (NS) 
Observational 
companson 
cross-sectional 
study 
Patients at participating 
centers, n = 781 
Telephone 
interviews of 
patients 
MuHiple patient-
centered Baseline measurements (done) 
outcomes. Control sites (yes) 
including Characterization of selected 
symptom sites (done). Standardization of 
control, self- outcomes (NS) Protection from 
management bias (retrospecti\-e, inter.iew-
counseling based measures 
Baseline measurements (NS) 
Control sites (none - sludy 
invol\-es only a discussion of t 
srte) Standard ization of 
in the Washington Observational, 
outcomes (none). Protection 
frombias (none mentioned) 
State Diabetes cross-sectional Patients at a partic ipating Protection from secular changes 
12 months 
12 months 
Collaborat ive study 
Medical 
records 
12clinical 
outcomes lor 
diabetes care (NS) Unclear 
Baseline Measurements (done) 
Control sites (NS) 
Medical Intermediate Characterization of selected 
Evaluation of 19- Patients at participating records, outcomes shes (done) Standard izationof 
member Diabetes Observational, centers (n= 969) QIC sur.-eys, related to outcomes (done) Protection 
Health Disparit ies Before-and-after partic ipants \i a surveys and qualitati\-e Diabetes from bias (NS) Protection from 
Chin et al, 2004 Diabetes Mellitus Collaborat il.-e study interviews (n=79) mellitus care secular changes (NS) 12 months 
Chin e! al, 2007 Diabetes Mellhus 
Acute Mi orHeart 
Fox. et al failure 
Homer et al 
(2005) Childhoodasthma 
l andon et al, 
2007 
Landon et al, 
20()4 
Mangione-Smhh 
et a1(2005) 
General Medical 
Care 
Patients with HIV 
infection 
Childhood asthma 
Before-after 
comparison of 
participating 
Evaluation of centers, with 
effect iveness of a embedded 
Health Disparit ies randomized 
Collaborative component 
Associations 
between 
collaborative 
participation and Cross -sectional 
Patients at participating 
centers in 1998, 2000and 
2002 (n = 2364, 2417, and 
2212. respectively) 
Medical 
records 
Self-report of 
compliance 
with pre 
imprD'.-ed quality of study (18 
months) 
Clinics partic ipating in OIC (n determined 
= 5) guidelines 
Al1alyzing the 
effect of practice-
le---e! interventions Clustered Interviews of 
on Pediatric 
asthma care 
randomized Clinics in greater Detroit and parents, via 
controlled uial Greater Boston areas {n = 43) telephone 
Case<ontrol 
Evaluation of 138 design, with 
Heahh Disparit ies matched internal 
Collaborat ive andexternal 
participants controls 
Case-<:ontrol 
design, using 
Community Health Centers 
Study of 62 of 
eligible 171 sites 
participating in 
CARE Act 
collaborative 
intervention sites Different types of medical 
andmatched centersdeli\-eringHIV c.:ne 
controls (n=62 intel\-ention sites) 
Sites participating 
in a BTS Quasi-
collaborative for experimental 
pediatricasthma before-and-after Patientsat participating and 
design selectedcontrol centers 
Randomly 
selected 
patient 
records 
Self-report of 
participating 
clinic s 
Medical 
records 
Sites partic ipating Quasi- Medical 
in BTS experimental records and 
collaborative for before-and-after Patients at participating and sur.-eys of Schonlau et at 
{2005) Childhoodasthma asthma care design selectedcontrol centers patients 
Philbin et al 
(2000) 
Siomos, et al 
{2005) 
Heart Failure 
Diabetes Mellitus 
~ Medical 
Study of t O  recordsand 
hospitals in i nterventi on Patients at participating and telephone 
upstate New York ~selected control centers interviews 
State Heahh 
Plans, 
participating in a Observational, 
Wisconsin Cross-sectional 
Collaborat r..-e analysis of Medical 
Project medical records Patients at participating plans records 
Numerous 
Baseline measurements (done) 
Control sites (nocontrol group 
for primarybefore-after analysis) 
Characterization of selected 
srtes (limiteddata) 
Standardization of outcome 
process-of<are measures (done) Protection 
and clinical from bias (RCT - yes, CS - no) 
Secular trends (discussed. not 
controlled for) 
Baseline measurements 
(unclear - only two measures 
presented). Control sites (state 
centers used as controls) 
Characterization of selected 
cites (NS). Standardization of 
outcome measures (done) 
HF compliance, Protection from bias {limited -
and AMI composite HF and AMI scores 
composite notdefined, nor arecomplete 
performance data available) Secular trends 
(NS) 
Baseline measurements (given. 
some detail) Control sites 
(some differences) 
Characterization of selected 
Primary and srtes (done). Standardization of 
secondary outcomes measures (done) 
asthma-related Protectionfrom bias 
Relevant 
Quality-of<are 
measures lor 
Diabetes. 
Asthma. 
Hypertension 
(randomization) 
Baseline Measurements (gil.-en) 
Control sites {yes, internal and 
external controls) 
Characterization of selected 
srtes (done) Standard ization of 
outcomes measures (yes) 
Protectionfrom bias (some 
sampling. measurement biases 
present). Seculartrends 
(discussed, unknown influence) 
Baseline measurements (small 
differences) Control sites 
(described) Characterist ics of 
selecterl sites {given) Blinded 
assessment (NS) 
HIV-related Randomization (no). Protection 
processof care from bias (statistical analytic 
outcomes techniques used minimize bias) 
Baseline measurements (some 
differences) Control sites 
(selected byreputational 
process) Blinded assessment 
(No) Randomization (no) 
Process-of<are Protection from bias 
and OOL (measurement bias likely , esp 
gil.-en non-blindedassessment 
Baseline measurements (none) 
Blinded assessment (yes) 
Characlerist ics of selected sites 
(infogi'-.-enfor patients, but not 
for sites themselves) 
Randomization (no). Protection 
from bias (potential for selection 
11 Quality bias based on site selection. 
indicators and 4 also unknownconfounders) 
processes-of- Secular trends (briefly 
discussed, nobefore-afterdata 
36 months 
24 months 
36 months 
Variable' 
18 months 
12 months 
available) 1J months 
Baseline measurements (small 
differences) Blinded 
assessment {no) 
Characterist ics of selected sites 
Process-of<are (given). Protection from bias 
and clinical (randomization). Seculartrends 
(NS) 18 months 
Baseline measurements (NS) 
Control sites (none) Blinded 
assessment (none) 
Randomization (no) Protection 
6 HEDIS quality from bias (NS, high potential for 
of care selection bias, baseline 
measures tor measurements not presented) 
OM Secular trends (not discussed) 36 monthst 
(+) effects of 
counseling, 
education 
inleMmtions 
(+) Effects of HF 
Fair 
OIC Fair 
(+) Effects of 
collaborative on 
lnc ratesof 
HbA1c. 
podiatry/eye 
referrals. and 
lipid 
Poor 
assessments Fair 
(+) effects on a 
number of 
processes and 
outcomes of 
(+) Effects on 
ACEI prescribing 
pattern s and 
HF/AMI 
No effect of 
intervention on 
pre-<letermined 
(+) Effects on 
preventionfscree 
n1ngprocesses 
ofcare No effect 
on clinical 
No significant 
effects on quality 
Fair 
Poor 
Fair 
Fair 
of care Good 
(+) Effects on 
selected 
processes of 
(+) Effects on 
some quality 
indicators and 
processes of 
No effect on 
most clinical 
outcomes Non-
significant 
reduction in 
hospital length-of-
stay in 
intervention 
Fair 
Poor 
group Good 
No statist ically 
significant effect 
on HEOIS 
diabetes care 
Poor 
Fair 
Fair 
Poor 
Fair 
Fair 
Poor 
Fair 
Good 
Good 
Poor 
Poor 
Fair 
Poor 
No 
Yes, some 
significant 
No 
No 
No 
No 
Yes, not 
significant 
Yes, not 
significant 
No 
Yes, not 
significant 
Yes, not 
significant 
Yes. not 
significant 
No 
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Appendix 3: Further Methods 
 
Web-Based Survey 
We developed a web-based survey designed using Qualtrics Survey Software to 
validate themes and concepts uncovered in the in-depth interviews and identify new ones by 
increasing the representative nature of our analysis and the potential for quantitative data 
analysis by efficiently reaching larger numbers of informed respondents. Surveying all relevant 
ICN participants, i.e. the entire ICN member population, allowed maximum power of our results.  
To capture the entire but limited universe of ICN participants, we asked experts in survey 
methodology and those with expertise in gastroenterology to review our survey rather than 
conduct a pilot. Expert reviewers included Anthony Viera (family physician and survey expert) 
and Greg Randolf (quality improvement expert in clinical settings). We provided the reviewers 
with a brief introduction of our study and the goals of the survey with an emphasis that to pilot 
the user groups would sacrifice our universe of participants, and asked them for critical 
feedback to improve the survey. Once we incorporated experts’ feedback, we asked two ICN 
members, Sandra Kim, MD, from University of North Carolina-Chapel Hill, and Amy Donegan, 
NP, from Nationwide Children’s Hospital in Columbus, OH, to evaluate the survey for clarity of 
questions and response options and ease of completion. We released the final survey to the 
ICN universe on June 2, 2010, and sent reminders to non-responders weekly for two weeks 
after the survey release. The final survey is available in Appendix 6.   
We uploaded survey results from Qualtrics to an Excel spreadsheet to tabulate 
descriptive statistics. Response rate was calculated. We quantified themes and concepts 
addressed by the survey and compared them to those uncovered in the qualitative interviews.  
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Observation of Participants at an ICN Learning Session 
We observed collaborative members at one of ICN's biannual learning sessions in 
Chicago, IL on April 9-11, 2010. The three-day session included an introductory day-long 
session for new centers joining the collaborative and two days of learning and research 
activities for all ICN members. We observed and recorded notes of participant activities as well 
as their interactions.  
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Figure A-3: Search Approach for Chronic Disease Collaborative Literature 
 
 
Inclusion criteria: Articles written about collaboratives targeted at one or more chronic diseases, met the definition 
of collaborative, took place in the U.S., and written in English. Definition of a collaborative: a voluntary network of 
health care providers in more than one health care system who agree to share data and information on processes 
of care for the purposes of improving quality of care and patient outcomes. 
Exclusion criteria: Articles about collaboratives (1) in settings of emergency departments, surgery, intensive care 
units, and general primary care without a specific disease focus; (2) focusing on organ donation, cancer screening, 
medical imaging, and palliative care.  
 
MEDLINE Advanced Search Terms:  
“quality” *all fields+ AND (“cooperative behavior” [MeSH Terms] OR “cooperative” *all fields+ AND 
“behavior” *all fields+ OR “collaborative” *all fields+) AND “improvement” *all fields+  
Limits: “humans” *MeSH Terms+ AND English *lang+ 
Date of Search: January 9, 2010 
Yield: 626 articles 
 
51 Articles meeting criteria, 
+ 
5 Articles meeting criteria from hand-
searched references 
Yield: 56 articles  
Inclusion Criteria: Studies addressing patient-oriented outcomes   
Exclusion criteria: Studies evaluating effective components of collaborative, i.e. teamwork or information 
technology, and studies examining exclusively non-disease specific outcomes. 
Process/Methods: 
19 articles 
  
Effectiveness: 
22 articles 
  
Sustainability: 
15 articles 
  
Yield: 13 articles 
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Appendix 4: Interview Protocol for Existing Sites 
 
ImproveCareNow (ICN) Pediatric IBD Collaborative:  Investigation into the Causes of 
Outcomes Improvement 
 
Fact Sheet/Interview Protocol/Script for in-depth interviews with key informants at 6 to 10 
participating institutions. 
[Introductory script, embedding study information and agreement to participate:] 
Hello, I am [Erica Peterson/Thomas Runge]. Thank you so much for talking with me today.  As 
you recall, I am one of the two research assistants working with Dr. Michael Kappelman and Dr. 
Sue Tolleson-Rinehart at the University of North Carolina to help evaluate improvement 
processes in the ImproveCareNow Collaborative.   
I am a medical student who is also earning the Master of Public Health degree at UNC.  Drs. 
Kappelman and Tolleson-Rinehart hope that this study of improvement processes at ICN will 
also become the subject of my master’s paper, and my fellow student’s master’s paper. 
We are interviewing collaborative members.  As we mentioned in our initial e-mail message, this 
interview contains several open-ended questions, and should last around 30 minutes, 
depending on the time you have to give and what you want to tell me.  We ask your permission 
to record the interview in order to assure we capture all you have to say as accurately as 
possible.  We will be furnishing you with a transcript of your interview, and will welcome any 
additional information you want to add to that. 
The intent of this study is to help the ICN Collaborative measure and understand what its 
improvement processes are accomplishing.  We do intend to use the data to complete two 
master’s papers, and we will try to publish those papers in the literature.  We will, of course, be 
making all findings available to the ICN Collaborative for its use.  You and your institution will be 
anonymous, but we do wish to use direct quotes from your interview. 
The ICN Collaborative Research Committee agrees to support the project, and the UNC IRB 
has determined that we are exempt. (IRB exemption # 09-2172).  Please don’t hesitate to ask 
any questions about the project – you may contact Dr. Kappelman at 
Michael_Kappelman@med.unc.edu or Dr. Tolleson-Rinehart at suetr@unc.edu.   
Before we continue, would you please give me a verbal agree to the statements I’m about to 
read?   
   I AGREE to having this interview tape recorded with a digital voice recorder.   
   I GIVE PERMISSION for the use of direct quotes from this interview for purposes of 
analysis. 
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Now we are ready to begin! 
1. First, we wanted to ask you your general impression of collaboratives, and what do you 
think motivates institutions to participate in them? 
 
2. And thinking about ICN particularly, what about participating in it has been most valuable 
to you as a health care provider who cares for children with IBD. 
 
3.   Now we would like to focus on specific ICN quality improvement activities. 
3.a. First, just off the top of your head, can you give me a list of all the activities the 
ICN has started?   
[If respondent does not understand, say “That is, just whatever comes to mind when you 
think of the initiatives or practice changes you are involved in because of ICN.”] 
3.b. And which of those things do you think have gone well? 
3.c. And which of those things do you think have not been so successful? 
 
4.  The next questions focus on the things YOU and YOUR INSTITUTION have done as a 
result of your participation in ICN.  Could you start by listing the changes that have been made 
at your institution as a result of the collaborative.  
 
5. To respect your time, we want to focus on what you think have been the most important 
things you’ve mentioned – the ones you think have been most important in driving improvement 
at your institution.   
In each case, we want to know your institution’s experience. 
5.a.  Which of the list you just gave me is the most important thing? 
[do repeat back] 
5.b. For [first thing,], can you describe it in more detail?  That is, tell me about how you 
put it into place at your institution, and how it went?  
 
[CHECKPOINTS:  if they DO NOT mention these things, go back and ask…] 
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 And when did that happen? 
 How long did it take to get it going? 
 What did you expect it would produce? 
 And about when did you expect to see results from it? 
 And where does it stand now?  Is it successful and ongoing?  Still being 
implemented?  Did it stop? 
 
 
6. [second thing] 
7. [third thing] 
8.  [fourth thing] 
 
Okay, thank you so much!  We are nearly done. 
 
Clearly, your commitment to the collaborative is strong – you have invested time and energy in 
it.  Thanks for telling me about your clinic. We also know from the data that outcomes appeared 
to have improved.  With that understood, we want to ask you to step back and think about how 
improvement happens in two last questions. 
 
9. First, do you think the outcomes improvement is a result of collaborative activity?  
[Pause] That is, do you think that the collaborative is already paying dividends, or that it is still 
too soon to have seen the effects on patient outcomes, or somewhere in between?   
 
10. Thank you for telling me about your clinic. Last, I’d like to ask you are there other 
changes that have occurred at your institution/center that may have affected outcomes (as 
measured by the collaborative database)?  
[Can you think of other changes that would have produced these results, such as changes in 
your center's provider and/or payer mix, leadership, etc.] 
 
Thank you!  That ends the interview.  We will be sending you a transcript soon!  Is there 
anything else you would like to tell us? 
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Appendix 5: Interview Protocol for New Sites 
 
ImproveCareNow (ICN) Pediatric IBD Collaborative: Investigation into the Causes of 
Outcomes Improvement 
 
Fact Sheet/Interview Protocol/Script for in-depth interviews with key informants at 2 to 3 new 
institutions. 
 
 
[Introductory script, embedding study information and agreement to participate:] 
 
Hello, I am [Erica Peterson/Thomas Runge]. Thank you so much for talking with me today.  As 
you recall, I am one of the two research assistants working with Dr. Michael Kappelman and Dr. 
Sue Tolleson-Rinehart at the University of North Carolina to help evaluate improvement 
processes in the ImproveCareNow Collaborative.   
 
I am a medical student who is also earning the Master of Public Health degree at UNC.  Drs. 
Kappelman and Tolleson-Rinehart hope that this study of improvement processes at ICN will 
also become the subject of my master’s paper, and my fellow student’s master’s paper. 
 
We are interviewing collaborative members.  As we mentioned in our initial e-mail message, this 
interview contains several open-ended questions, and should last around 30 minutes, 
depending on the time you have to give and what you want to tell me.  We ask your permission 
to record the interview in order to assure we capture all you have to say as accurately as 
possible.  We will be furnishing you with a transcript of your interview, and will welcome any 
additional information you want to add to that. 
 
The intent of this study is to help the ICN Collaborative measure and understand what its 
improvement processes are accomplishing.  We do intend to use the data to complete two 
master’s papers, and we will try to publish those papers in the literature.  We will, of course, be 
making all findings available to the ICN Collaborative for its use.  You and your institution will be 
anonymous, but we do wish to use direct quotes from your interview. 
 
The ICN Collaborative Research Committee agrees to support the project, and the UNC IRB 
has determined that we are exempt. (IRB exemption # 09-2172).  Please don’t hesitate to ask 
any questions about the project – you may contact Dr. Kappelman at 
Michael_Kappelman@med.unc.edu or Dr. Tolleson-Rinehart at suetr@unc.edu.   
 
Before we continue, would you please give me a verbal agree to the statements I’m about to 
read?   
 
   I AGREE to having this interview tape recorded with a digital voice recorder.   
 
   I GIVE PERMISSION for the use of direct quotes from this interview for purposes of 
analysis. 
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Now we are ready to begin! 
 
1. First, we wanted to ask you your general impression of collaboratives? What do you 
think motivates institutions in general to participate in them? 
 
 
1.a. And what made you and your institution interested in participating in these kinds 
of activities? 
 
 
2. And thinking about your joining ICN particularly, what do you expect will be most 
valuable to you as a health care provider who cares for children with IBD?  
 
[That is, what improvements do you hope to see through your participation in ICN?] 
 
 
3.   Now, we would like to focus specifically on quality improvement activities.  
 
3.a. Are there any particular activities you have already started at your clinic to 
improve the quality of care for your patients? 
 
 
[If yes,]  
3.b. And which of those things do you think have gone well? 
 
 
3.c. And which of those things do you think have not been so successful? 
 
 
4.  What are the challenges/obstacles you face in implementing quality improvement 
activities?  
 
 
Okay, thank you so much!  We are nearly done: 
 
In our final question, we want to ask you to step back and think about how quality improvement 
happens. As you may know, ICN collects various data, including certain patient outcomes. 
 
 
5. What factors do you think are important for measuring outcomes improvement?  
 
 
 
Thanks for telling me about your clinic and your expectations in participating in ICN. That ends 
the interview.  We will be sending you a transcript soon!  Is there anything else you would like to 
tell us? 
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Appendix 6: Web-Based Survey 
 
1. We can determine when all sites joined ICN, but we are interested in when YOU think YOUR site 
became fully engaged in ICN and its activities.  Please estimate the year you think your center became 
fully engaged. 
a) 2007 
b) 2008 
c) 2009 
d) 2010 
e) Our center is not yet fully engaged 
 
2. What types of health professionals are involved with IBD patients in your pediatric IBD program (not 
necessarily as a part of ICN)?   Select all that apply. 
a) Physicians 
b) Mid-level providers (PAs, NPs, etc.) 
c) Nurses 
d) Clinical pharmacists who are assigned to the program 
e) Nurses assistants or medical assistants 
f) Nutritionists, dietitians 
g) Psychologists or psychiatrists 
h) Social workers 
i) Financial counselor 
j) Other:   Please specify   ___________ 
 
3. What best describes you? If you have more than one role, please choose the one that is most 
applicable right now, to the pediatric IBD program at your center. 
a) I am a physician who cares for patients with IBD 
b) I am a mid-level provider (NP, PA) 
c) I am a pharmacist 
d) I am a nurse 
e) I am a dietitian 
f) I am a research assistant 
g) I am a quality improvement specialist  
h) Other:   Please specify   ___________ 
 
3a. Please estimate what fraction of your total IBD patient population is actively followed in the ICN 
database (e.g. most visits for these patients are entered) 
a) Less than 20% 
b) Between 20% and 40% 
c) Between 40% and 60%  
d) Between 60% and 80% 
e) More than 80% 
f) Unable to estimate 
 
4.  The statements below are a list of things people have told us about why the ICN collaborative is 
important to them.  Please use the slider bars (0-10) below to tell us how important or unimportant 
each of these things is to YOU and YOUR involvement in ICN.  If something does not matter to you AT 
ALL, please drag the slider bar to zero. 
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a) Using quality improvement strategies to help patients 
 
b) Helping health care providers learn leadership skills 
 
c) Working together and sharing with providers at other centers 
 
d) An opportunity for research 
 
e) Developing, agreeing to, and using best practice standards 
 
f) Other - Please specify. 
 
 
 
5.  As a health care provider, what has been (or what do you expect to be) the SINGLE most valuable 
aspect of being a member in ImproveCareNow? 
a) Using quality improvement strategies to help patients 
b) Helping health care providers learn leadership skills 
c) Working together and sharing with providers at other centers 
d) An opportunity to do research 
e) Developing, agreeing to, and using best practice standards 
f) Other:   Please specify   ___________ 
 
6.  If you have used any of the following activities, please move the slider bars below to rate each of the 
following according to HOW VALUABLE THEY ARE to improving the care of IBD patients at your center.   
If things are NOT VALUABLE at all, please move the slider bar to zero, to make sure your choice registers. 
If you have NEVER DONE an activity, check the box “Not Applicable.” 
In the “other” option, if you have no additional comments, please select “Not applicable.” 
a) Standardized IBD Clinic Template 
 
b) Model Care Guidelines 
 
c) Nutrition/Growth Algorithms 
 
d) Dedicated IBD Clinic 
 
e) Monthly Narrative Reports submitted to ICN 
 
f) Running small tests of change (PDSAs) at your site 
 
g) Pre-visit planning 
 
h) Regular meetings to discuss patients from Population Management Reports (PMR) 
 
i) Multidisciplinary team meetings, other than those used to discuss PMR 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
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j) Real-time process auditing 
 
k) Patient self-management support (e.g. education sessions, support groups, materials) 
 
l) Other – Please specify  
 
 
 
7.  ICN provides several services and educational opportunities to its sites.  Now we’d like you to rate the 
value of each of the following.  IF YOU HAVE USED any of the following activities, please MOVE the slider 
bars below to rate each according to HOW VALUABLE THEY ARE to improving the care of IBD patients at 
your center.  
If things are not valuable at all, please move the slider bar to zero, to be sure your choice registers. 
If you HAVE NEVER USED an activity, check the box “Not Applicable.” 
In the “Other” option, if you have no additional comments, please select “Not applicable.” 
a) Conference calls and webinars 
 
b) Email/Listserv 
 
c) Extranet 
 
d) Monthly data reporting from ICN 
 
e) Population management reports 
 
f) Semi-annual Learning Sessions 
 
g) Other – please describe. 
 
 
8. Below are some potential obstacles to participation in ICN.   Please use the slider bars to indicate how 
challenging these factors are, at your center.  If one or more of these is NOT a challenge for your site, 
please move the slider bar to zero.   
If you don’t know or cannot assess, please check the box “Not Applicable.” 
In the “Other” option, if you have no additional comments, please select “Not Applicable." 
a) Financial Costs 
 
b) It takes my time 
 
c) It takes the time of other staff 
 
d) It takes time to see change 
 
e) Clinic restructuring 
 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
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f) Transition to electronic medical records (EMR), or other changes to medical record 
 
g) Turnover of specific, key personnel 
 
h) Lack of leadership commitment to ICN, or QI in general. 
 
i) Difficulty changing the practices of physicians, nurses, and staff 
 
j) Other – Please specify. 
 
 
9. Finally, please address the relative effect of each of the variables below on improved patient 
outcomes in ICN, since 2007.  Please MOVE the slider bars below to rate each of the following according 
to HOW IMPORTANT THEY ARE to improving patient outcomes. 
If things are NOT IMPORTANT at all, please MOVE the slider bar to zero, to be sure your choice registers. 
If you don’t know or cannot assess, please check the box “Not Applicable.” 
In the “OTHER” column, if you have no additional comments, please select “Not Applicable.” 
a) Improved medication management, as a result of scientific or therapeutic advances. 
 
b) Continuing education about IBD, independent of ICN 
 
c) Other secular trends, that is, changes in medicine generally that affect all practices 
 
d) Natural stabilization of the course of disease over time, occurring idnependent of ICN 
 
e) Other changes in your practice (addition or loss of key physicians, nurses, or other staff) 
 
f) New patient-parent support mechanisms unrelated to ICN 
 
g) Variation in scoring of the PGA (Physician Global Assessment) 
 
h) How patients were entered into the database (i.e., early on, sicker patients more likely to be 
entered due to frequency of clinic visits compared to healthier patients) 
 
i) The ImproveCareNow collaborartive intervention 
 
j) Other – Please specify. 
 
 
 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
0 1 2 3 4 5 6 7 8 9 10 
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